Bayer AG won a reprieve as a federal judge cut a verdict linking its Roundup weedkiller to cancer by $55 million, while the German company continues to fight thousands of lawsuits in the U.S.
The stock rose as much as 2.4% in Frankfurt trading after U.S. District Judge Vince Chhabria ruled Monday that the March verdict intended to punish the company was too high.
Bayer’s future growth is clouded by thousands of legal cases filed by people who argue Roundup is to blame for their cancer, leading shareholders to question its decision to buy U.S. seed and pesticide giant Monsanto ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.